Home > new developments > EARLY DIAGNOSTICS OF THROMBO-FORMATION THREATS: A TEST SYSTEM OF IMMUNO-ENZYMATE FOR QUANTITATIVE DETERMINATION OF SOLUBLE FIBRIN AND D-DIMER IN HUMAN BLOOD PLASMA

EARLY DIAGNOSTICS OF THROMBO-FORMATION THREATS: A TEST SYSTEM OF IMMUNO-ENZYMATE FOR QUANTITATIVE DETERMINATION OF SOLUBLE FIBRIN AND D-DIMER IN HUMAN BLOOD PLASMA

PURPOSE:

The enzyme immunoassay test systems were developed using the obtained monoclonal antibodies highly specific for human fibrin and D-dimer, respectively, in the composition of an immunosorbent. The principle of the analysis is based on a bisite enzyme-linked immunosorbent assay with signal amplification due to the formation of a biotin-streptavidin-peroxidase complex. The absence of a cross-reaction of monoclonal antibodies that make up the immunosorbent with fibrinogen and other proteins of the blood coagulation system provides a high specificity of the test systems. Approved: in the leading clinics of Ukraine and received positive reviews and recommendations from a number of famous professors of these clinics. State registration received.

ADVANTAGES:

    • high accuracy of the method;
    • the uniqueness of the technology of the innovative product (the use of unique specific antibodies of our own production);
    • low cost.

RECOMMENDED FIELD OF APPLICATION:

Medicine. Cardiology, surgery, vascular surgery, gynecology, oncology, endocrinology, traumatology, combustiology.

RESULTS OF THE RESEARCH:

Provides consistent results.

STAGE OF THE DEVELOPMENT READINESS:

Tested in trial operation.

TRANSFER OPPORTUNITY:

Joint making available to industrial level.

NOVELTY:

2 patents of Ukraine.

 

IF YOU ARE INTERESTED IN THIS DEVELOPMENT, PLEASE,

WRITE TO US

Leave a Reply

Your email address will not be published. Required fields are marked *